Actinogen Medical (Australia) Price Prediction
| ACW Stock | 0.03 0 3.85% |
Oversold Vs Overbought
40
Oversold | Overbought |
EPS Estimate Current Year (0.01) | Wall Street Target Price 0.15 | Quarterly Revenue Growth 1.323 |
Using Actinogen Medical hype-based prediction, you can estimate the value of Actinogen Medical from the perspective of Actinogen Medical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Actinogen Medical to buy its stock at a price that has no basis in reality. In that case, they are not buying Actinogen because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Actinogen Medical after-hype prediction price | AUD 0.03 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Actinogen |
Actinogen Medical After-Hype Price Prediction Density Analysis
As far as predicting the price of Actinogen Medical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Actinogen Medical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Actinogen Medical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Actinogen Medical Estimiated After-Hype Price Volatility
In the context of predicting Actinogen Medical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Actinogen Medical's historical news coverage. Actinogen Medical's after-hype downside and upside margins for the prediction period are 0.00 and 4.95, respectively. We have considered Actinogen Medical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Actinogen Medical is out of control at this time. Analysis and calculation of next after-hype price of Actinogen Medical is based on 3 months time horizon.
Actinogen Medical Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Actinogen Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Actinogen Medical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Actinogen Medical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.68 | 4.88 | 0.00 | 0.02 | 0 Events / Month | 2 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.03 | 0.03 | 20.00 |
|
Actinogen Medical Hype Timeline
Actinogen Medical is presently traded for 0.03on Australian Securities Exchange of Australia. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. Actinogen is anticipated to increase in value after the next headline, with the price projected to jump to 0.03 or above. The average volatility of media hype impact on the company the price is insignificant. The price appreciation on the next news is anticipated to be 20.0%, whereas the daily expected return is presently at -0.68%. The volatility of related hype on Actinogen Medical is about 20914.29%, with the expected price after the next announcement by competition of 0.05. Actinogen Medical has accumulated 319.07 K in total debt. Debt can assist Actinogen Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Actinogen Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Actinogen Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Actinogen to invest in growth at high rates of return. When we think about Actinogen Medical's use of debt, we should always consider it together with cash and equity.Assuming the 90 days trading horizon the next anticipated press release will be in 5 to 10 days. Check out Actinogen Medical Basic Forecasting Models to cross-verify your projections.Actinogen Medical Related Hype Analysis
Having access to credible news sources related to Actinogen Medical's direct competition is more important than ever and may enhance your ability to predict Actinogen Medical's future price movements. Getting to know how Actinogen Medical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Actinogen Medical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ATM | Aneka Tambang Tbk | 0.00 | 2 per month | 0.00 | (0.17) | 0.00 | (0.97) | 16.07 | |
| RIO | Rio Tinto | (0.71) | 5 per month | 1.35 | (0.03) | 3.43 | (2.27) | 7.08 | |
| BHP | BHP Group Limited | 0.02 | 4 per month | 1.49 | (0.07) | 2.73 | (2.39) | 7.92 | |
| SQ2 | Block Inc | 0.14 | 3 per month | 1.51 | 0.20 | 4.35 | (2.62) | 13.06 | |
| SUN | Suncorp Group | 0.27 | 2 per month | 0.65 | 0.06 | 2.08 | (1.33) | 4.07 | |
| ALL | Aristocrat Leisure | 0.48 | 1 per month | 0.86 | 0.18 | 2.12 | (1.97) | 5.18 | |
| PLS | Pilbara Minerals | 0.04 | 4 per month | 0.00 | (0.1) | 5.69 | (5.18) | 19.92 | |
| NEM | NEWMONT PORATION CDI | 0.00 | 0 per month | 0.00 | (0.14) | 2.58 | (4.25) | 17.46 | |
| WHC | Whitehaven Coal | (0.03) | 2 per month | 1.91 | (0.06) | 4.34 | (2.92) | 9.22 |
Actinogen Medical Additional Predictive Modules
Most predictive techniques to examine Actinogen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Actinogen using various technical indicators. When you analyze Actinogen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Actinogen Medical Predictive Indicators
The successful prediction of Actinogen Medical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Actinogen Medical, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Actinogen Medical based on analysis of Actinogen Medical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Actinogen Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Actinogen Medical's related companies.
Story Coverage note for Actinogen Medical
The number of cover stories for Actinogen Medical depends on current market conditions and Actinogen Medical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Actinogen Medical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Actinogen Medical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Actinogen Medical Short Properties
Actinogen Medical's future price predictability will typically decrease when Actinogen Medical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Actinogen Medical often depends not only on the future outlook of the potential Actinogen Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Actinogen Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.2 B | |
| Cash And Short Term Investments | 9.5 M |
Additional Tools for Actinogen Stock Analysis
When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.